BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27552533)

  • 41. Borderline Personality Disorder and Outcome of Electroconvulsive Therapy in Patients With Depression: A Systematic Review.
    Nicolini AP; Sienaert P
    J ECT; 2023 Jun; 39(2):74-80. PubMed ID: 36821825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
    Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
    Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: A systematic review and multiple-treatments meta-analysis.
    Chen JJ; Zhao LB; Liu YY; Fan SH; Xie P
    Behav Brain Res; 2017 Mar; 320():30-36. PubMed ID: 27876667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.
    Palm U; Fintescu Z; Obermeier M; Schiller C; Reisinger E; Keeser D; Pogarell O; Bondy B; Zill P; Padberg F
    J Affect Disord; 2013 Sep; 150(2):659-63. PubMed ID: 23664268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electroconvulsive therapy for major depressive disorder in a patient with a permanent skull defect: a case report.
    Roh J; Kang MH; Kim CE; Lee JS; Bae JN
    Asia Pac Psychiatry; 2014 Dec; 6(4):454-7. PubMed ID: 25425066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Local functional connectivity density is closely associated with the response of electroconvulsive therapy in major depressive disorder.
    Wang J; Wei Q; Yuan X; Jiang X; Xu J; Zhou X; Tian Y; Wang K
    J Affect Disord; 2018 Jan; 225():658-664. PubMed ID: 28910748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a meta-analysis of stimulus parameter effects.
    Xie J; Chen J; Wei Q
    Neurol Res; 2013 Dec; 35(10):1084-91. PubMed ID: 23889926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significant treatment effect of add-on ketamine anesthesia in electroconvulsive therapy in depressive patients: A meta-analysis.
    Li DJ; Wang FC; Chu CS; Chen TY; Tang CH; Yang WC; Chow PC; Wu CK; Tseng PT; Lin PY
    Eur Neuropsychopharmacol; 2017 Jan; 27(1):29-41. PubMed ID: 27908572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prelimbic Stimulation Ameliorates Depressive-Like Behaviors and Increases Regional BDNF Expression in a Novel Drug-Resistant Animal Model of Depression.
    Moshe H; Gal R; Barnea-Ygael N; Gulevsky T; Alyagon U; Zangen A
    Brain Stimul; 2016; 9(2):243-50. PubMed ID: 26655599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of BDNF and memory in major depressive disorder.
    Adlam J; Zaman R
    Psychiatr Danub; 2013 Sep; 25 Suppl 2():S368-9. PubMed ID: 23995212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Pattern of Change in Depressive Symptoms and Inflammatory Markers After Electroconvulsive Therapy: A Systematic Review.
    Desfossés CY; Peredo R; Chabot A; Carmel JP; Tremblay PM; Mérette C; Picher G; Lachance I; Patry S; Lemasson M
    J ECT; 2021 Dec; 37(4):291-297. PubMed ID: 34294652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered brain-derived neurotrophic factor expression in the ventral tegmental area, but not in the hippocampus, is essential for antidepressant-like effects of electroconvulsive therapy.
    Taliaz D; Nagaraj V; Haramati S; Chen A; Zangen A
    Biol Psychiatry; 2013 Aug; 74(4):305-12. PubMed ID: 22906519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electroconvulsive therapy changes the regional resting state function measured by regional homogeneity (ReHo) and amplitude of low frequency fluctuations (ALFF) in elderly major depressive disorder patients: An exploratory study.
    Kong XM; Xu SX; Sun Y; Wang KY; Wang C; Zhang J; Xia JX; Zhang L; Tan BJ; Xie XH
    Psychiatry Res Neuroimaging; 2017 Jun; 264():13-21. PubMed ID: 28412557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome.
    van Zutphen EM; Rhebergen D; van Exel E; Oudega ML; Bouckaert F; Sienaert P; Vandenbulcke M; Stek M; Dols A
    Transl Psychiatry; 2019 May; 9(1):155. PubMed ID: 31127089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia-A Systematic Review and Meta-Analysis.
    Szota AM; Kowalewska B; Ćwiklińska-Jurkowska M; Dróżdż W
    J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic mechanisms of electroconvulsive therapy response in depression.
    Benson-Martin JJ; Stein DJ; Baldwin DS; Domschke K
    Hum Psychopharmacol; 2016 May; 31(3):247-51. PubMed ID: 27062668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.
    Kranaster L; Hellweg R; Sartorius A
    Neurosci Lett; 2019 Jun; 704():164-168. PubMed ID: 30978454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ketamine in electroconvulsive therapy for depressive disorder: A systematic review and meta-analysis.
    Ren L; Deng J; Min S; Peng L; Chen Q
    J Psychiatr Res; 2018 Sep; 104():144-156. PubMed ID: 30077114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in Cognitive Outcomes After ECT Depending on BDNF and COMT Polymorphisms.
    Bennett DM; Currie J; Fernie G; Perrin JS; Reid IC
    J ECT; 2016 Dec; 32(4):243-250. PubMed ID: 27191122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis.
    Meshkat S; Alnefeesi Y; Jawad MY; D Di Vincenzo J; B Rodrigues N; Ceban F; Mw Lui L; McIntyre RS; Rosenblat JD
    Psychiatry Res; 2022 Nov; 317():114857. PubMed ID: 36194941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.